Embecta (Nasdaq:EMBC) announced a new publication introducing best practices for insulin injection techniques and education.
Glucotrack (Nasdaq:GCTK) announced that it expects FDA investigational device exemption for its long-term CBGM later this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback